Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Breast cancer proteomics: clinical perspectives.

Lau TY, O'Connor DP, Brennan DJ, Duffy MJ, Pennington SR, Gallagher WM.

Expert Opin Biol Ther. 2007 Feb;7(2):209-19. Review.

PMID:
17250459
2.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
3.

Implications of applied research for prognosis and therapy of breast cancer.

Barginear MF, Bradley T, Shapira I, Budman DR.

Crit Rev Oncol Hematol. 2008 Mar;65(3):223-34. doi: 10.1016/j.critrevonc.2007.11.004. Review.

PMID:
18243013
4.

Proteomics of breast cancer: the quest for markers and therapeutic targets.

Hondermarck H, Tastet C, El Yazidi-Belkoura I, Toillon RA, Le Bourhis X.

J Proteome Res. 2008 Apr;7(4):1403-11. doi: 10.1021/pr700870c. Epub 2008 Feb 27. Review.

PMID:
18311906
5.

Clinical application of proteomics in breast cancer: state of the art and perspectives.

Goncalves A, Bertucci F.

Med Princ Pract. 2011;20(1):4-18. doi: 10.1159/000319544. Epub 2010 Dec 13. Review.

6.

Perspectives of clinical proteomics in gastrointestinal cancer.

Ebert M, Xing X, Burgermeister E, Schmid R, Röcken C.

Expert Rev Anticancer Ther. 2007 Apr;7(4):465-9. Review.

PMID:
17428167
7.

Proteomics in cancer research.

Wu W, Hu W, Kavanagh JJ.

Int J Gynecol Cancer. 2002 Sep-Oct;12(5):409-23. Review.

PMID:
12366655
8.

Proteomic analysis of bone cancer: a review of current and future developments.

Bhattacharyya S, Byrum S, Siegel ER, Suva LJ.

Expert Rev Proteomics. 2007 Jun;4(3):371-8. Review.

PMID:
17552921
10.

[Proteomics and breast cancer: new perspectives and limitations].

Hondermarck H.

Pathol Biol (Paris). 2006 May;54(4):194-8. Epub 2006 May 2. Review. French.

PMID:
16632259
11.

Breast cancer: when proteomics challenges biological complexity.

Hondermarck H.

Mol Cell Proteomics. 2003 May;2(5):281-91. Epub 2003 May 29. Review.

12.

Clinical infrastructures to support proteomic studies of tissue and fluids in breast cancer.

Mouridsen HT, Brünner N.

Mol Cell Proteomics. 2004 Apr;3(4):302-10. Epub 2004 Feb 3. Review.

13.

Proteomics in gerontology: current applications and future aspects--a mini-review.

Schiffer E, Mischak H, Zimmerli LU.

Gerontology. 2009;55(2):123-37. doi: 10.1159/000191653. Epub 2009 Jan 9. Review.

14.

Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.

Castronovo V, Kischel P, Guillonneau F, de Leval L, Deféchereux T, De Pauw E, Neri D, Waltregny D.

Proteomics. 2007 Apr;7(8):1188-96.

PMID:
17372937
15.

[Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].

Gilabert M, Audebert S, Viens P, Borg JP, Bertucci F, Gonçalves A.

Bull Cancer. 2010 Mar;97(3):321-39. doi: 10.1684/bdc.2010.1061. Review. French.

16.

Gene diagnostics provide new insights into breast cancer prognosis and therapy.

Benz CC, Brandt BH, Zänker KS.

Gene. 1995 Jun 14;159(1):3-7. Review.

PMID:
7607570
17.

Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.

Bharti A, Ma PC, Salgia R.

Mass Spectrom Rev. 2007 May-Jun;26(3):451-66. Review.

PMID:
17407130
18.

Proteins' promise--progress and challenges in ovarian cancer proteomics.

Koehn H, Oehler MK.

Menopause Int. 2007 Dec;13(4):148-53. Review.

PMID:
18088525
19.

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.

J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5.

PMID:
18318472
20.

Oncoproteomics: current trends and future perspectives.

Cho WC, Cheng CH.

Expert Rev Proteomics. 2007 Jun;4(3):401-10. Review.

PMID:
17552924

Supplemental Content

Support Center